Registration dossiers and type test packages should be organized against the new standard requirements.
Test Systems
GtestWorks Automated Testing Platform
VectWorks 3.0 Electrical Performance Test Software
This page interprets YY/T 1874-2023, EMC test protocols for active implantable medical devices, with a focus on implantable cardiac pacemakers, implantable cardioverter defibrillators, and cardiac resynchronization devices. It covers the regulatory background, device scope, core EMC test items, clinical environment protection requirements, manufacturer documentation obligations, and the main differences from YY 9706.102-2021.
If you are preparing regulatory registration or a laboratory test plan, start with the standard profile, core test items, and comparison with YY 9706.102. If your priority is clinical environment risk, jump directly to the clinical protection and accompanying document sections.
YY/T 1874-2023 is a dedicated EMC test protocol for implantable cardiac devices. It spans critical electromagnetic environments from DC to 3 GHz and is intended to verify that pacemakers, ICDs, CRT-P devices, and CRT-D devices maintain basic safety and essential function under realistic electromagnetic exposure conditions.
Registration dossiers and type test packages should be organized against the new standard requirements.
It covers low-frequency magnetic fields, RFID, wireless communication, and high-frequency radiated field scenarios.
The main target categories are pacemakers, ICDs, CRT-P, and CRT-D devices.
The standard is identically adopted from ISO 14117:2019, which helps align domestic and international test logic.
Unlike general medical EMC standards, YY/T 1874-2023 is primarily concerned with whether an implantable device is falsely triggered, inhibited, reconfigured, or permanently damaged by external electromagnetic fields. The emphasis is the stability of the implanted device itself.
Mobile phones, RFID, EAS gates, metal detectors, MRI systems, RF surgery, and wireless charging systems all introduce exposure conditions that directly shape the evolution of this standard.
If your product is an implantable pacemaker, defibrillator, or cardiac resynchronization therapy device, EMC is not merely a supplement to a general medical electrical standard. It becomes a core requirement tied to registration compliance, clinical safety, and completeness of the accompanying documentation.
This section helps teams quickly confirm the standard attributes, regulatory significance, and its relationship with ISO 14117:2019 so they can establish a basic framework for test planning and registration documentation.
| Item | Content |
|---|---|
| Standard No. | YY/T 1874-2023 |
| Chinese Title | 有源植入式医疗器械 电磁兼容 植入式心脏起搏器、植入式心律转复除颤器和心脏再同步器械的电磁兼容测试细则 |
| English Title | Active implantable medical devices - Electromagnetic compatibility - EMC test protocols for implantable cardiac pacemakers, implantable cardioverter defibrillators and cardiac resynchronization devices |
| Release Date | 2023-03-14 |
| Implementation Date | 2024-05-01 |
| Issuing Authority | National Medical Products Administration |
| Adoption | ISO 14117:2019, IDT |
The electromagnetic environment faced by implantable cardiac devices is far more complex than that of general medical electrical equipment. At the low-frequency end, the exposure sources include EAS, RFID, metal detectors, MRI systems, and wireless charging systems. At the high-frequency end, the exposure sources include mobile phones, radios, and other handheld wireless transmitters. If the device experiences inhibition, inappropriate therapy, parameter drift, or permanent damage in those scenarios, the consequences may directly threaten patient life.
| Revision Topic | Details |
|---|---|
| New definitions | Added terms such as interference mode and transient exposure |
| Frequency boundary change | The boundary between conducted injection and radiated testing was shifted from 450 MHz to 385 MHz |
| New Clause 4.10 | Introduced transient exposure requirements from 16.6 Hz to 167 kHz |
| Recognition of multi-pole lead systems | Formally recognizes IS-4, DF-4, and other multi-port, multi-electrode systems |
| New Clause 7.4 | Requires disclosure of minimum separation distances from handheld transmitters |
The applicability boundary of YY/T 1874-2023 determines not only whether a test item applies, but also how unipolar and bipolar settings, grouping logic, interface circuits, and evaluation criteria should be selected.
| Frequency Range | Description |
|---|---|
| 0 Hz ≤ f < 385 MHz | Covers power-frequency magnetic fields, low-frequency induction, RFID, EAS systems, and wireless charging related scenarios |
| 385 MHz ≤ f ≤ 3000 MHz | Targets mobile phones, radios, and other handheld wireless communication sources |
This standard mainly addresses pulse generators used with transvenous or epicardial lead systems. For products such as S-ICD or leadless pacemakers that do not use conventional lead structures, manufacturers should adapt the test logic according to the device architecture.
| Device Type | Grouping | Description |
|---|---|---|
| Single-channel unipolar device | Group a | The tip end is connected to output terminal D and the can is connected to the enclosure port |
| Multi-channel unipolar device | Group b | Each channel is connected in turn to the output terminal for multi-chamber unipolar systems |
| Single-channel bipolar device | Group c | Tip and ring are connected to their respective outputs and both common-mode and differential-mode tests apply |
| Multi-channel bipolar device | Group d | Applies to multi-chamber, multi-port bipolar systems |
| Configuration | Loop Area | Typical Test Level | Description |
|---|---|---|---|
| Unipolar sensing | Large, typically referenced to 225 cm² | 100% test level | Large loop area means stronger coupling and a more severe worst-case condition |
| Bipolar sensing | About 10% of unipolar | 10% test level | The shorter tip-to-ring distance significantly reduces induced voltage |
The main body of the standard consists of dedicated EMC tests built around frequency ranges, fault modes, and function-specific device risks. The emphasis is not on general emission limits, but on whether the device can continue to deliver correct therapy during exposure.
| Clause | Test Item | Frequency Range | Purpose |
|---|---|---|---|
| 4.2 | Induced current in electrode leads | 0-140 kHz | Evaluates whether induced current in the leads exceeds safety limits |
| 4.3 | Protection against continuous fault from ambient fields | 16.6 Hz-10 MHz | Verifies functional integrity under sustained exposure |
| 4.4 | Short-duration CW exposure | 0 Hz-10 MHz | Observes recovery behavior and fault risk after brief continuous-wave exposure |
| 4.5 | EMI sensed as cardiac signals | 0 Hz-10 MHz | Prevents pacing inhibition, inappropriate tracking, and false ICD therapy |
| 4.6 / 4.7 | Static magnetic field protection | 0 Hz | Evaluates the effect of 1 mT and 50 mT static magnetic field exposure |
| 4.8 | AC magnetic field exposure protection | 1 kHz-140 kHz | Covers RFID, wireless charging, and induction heating applications |
| 4.9 | Radiated high-frequency field test | 385 MHz-3 GHz | Evaluates the effect of mobile phones and other wireless devices |
| 4.10 | Transient exposure test | 16.6 Hz-167 kHz | Verifies transient response under pulsed or intermittent magnetic fields |
This test is based on the principle of electromagnetic induction. It looks at whether low-frequency magnetic fields passing through the lead loop create induced currents above the allowable limit. A 225 cm² planar semicircular reference loop is commonly used as a conservative maximum-coupling condition.
Clause 4.3 is more concerned with inhibition, irreversible parameter changes, or loss of function during exposure lasting tens of seconds to minutes. Clause 4.4 emphasizes transient anomalies caused by second-level exposure and the device ability to recover afterward. Together they describe the practical EMC resilience of the implant.
| Frequency Range | Unipolar Limit | Bipolar Limit | Applicable Port |
|---|---|---|---|
| 0-140 Hz | 100 mA | 10 mA | Sensing / pacing port |
| 140 Hz-1 kHz | 100 mA | 10 mA | Sensing / pacing port |
| 1 kHz-10 kHz | 100 mA | 10 mA | Sensing / pacing port |
| 10 kHz-140 kHz | 100 mA | 10 mA | Sensing / pacing port |
| 0-140 kHz | 50 mA | 50 mA | Cardioversion / defibrillation port |
| Frequency Range | Unipolar Test Amplitude | Bipolar Test Amplitude | Scenario |
|---|---|---|---|
| 16.6 Hz-1 kHz | 1000 mV peak | 100 mV peak | Protection against continuous ambient-field fault |
| 1 kHz-10 kHz | 1000 mV peak | 100 mV peak | Protection against continuous ambient-field fault |
| 10 kHz-100 kHz | 500 mV peak | 50 mV peak | Protection against continuous ambient-field fault |
| 100 kHz-1 MHz | 200 mV peak | 20 mV peak | Protection against continuous ambient-field fault |
| 1 MHz-10 MHz | 100 mV peak | 10 mV peak | Protection against continuous ambient-field fault |
Clause 6 specifically addresses high-risk exposure scenarios in clinical practice, including high-frequency electrosurgery and external defibrillation. These tests correspond to some of the most severe electromagnetic shocks encountered in hospitals.
| Test Item | Typical Parameter / Condition | Acceptance Criteria |
|---|---|---|
| High-frequency electrosurgery exposure | Simulated surgical-frequency current to evaluate lead and circuit protection | No visible damage, full function retained, parameters unchanged, no abnormal heating |
| External defibrillation exposure | Typical biphasic waveform, 2000 V, 30 A peak, 10-20 ms | Device function retained, no need for re-adjustment, battery status normal |
Interference in hospitals is not always a stable continuous field. It may combine high-energy pulses, coupling through metallic instruments, changes in lead routing, and variability in patient physiology. The value of Clause 6 is therefore not simply that it adds two more tests, but that it brings key clinical risks into the pre-market verification stage.
YY/T 1874-2023 does not stop at laboratory testing. It also requires manufacturers to disclose sufficient EMC risk information in the instructions for use and technical documents so clinicians and patients can use the device appropriately.
| Documentation Requirement | Description |
|---|---|
| Permanent programmable sensitivity settings | Programmable options and default values should be stated so users understand EMC behavior under different sensitivity settings |
| Fallback mode description | The manufacturer should describe whether the device may enter noise-following mode, magnetic mode, or backup mode under EMI |
| Known potentially hazardous behaviors | The documentation should disclose the electromagnetic field types and scenarios that may cause inhibition, inappropriate therapy, or damage |
| Minimum distance from handheld transmitters | Recommended separation distances for mobile phones, radios, Bluetooth devices, and similar sources should be stated |
Unipolar or bipolar, single-chamber or multi-chamber, pacing mode or defibrillation mode all affect grouping and interface connections.
Use Annex I to choose sensitivity, output, detection, and therapy settings so the test reflects a justified worst-case condition.
Do not leave EMC warnings and separation guidance to the end of the registration cycle. Documentation disclosure is part of compliance itself.
Test data should map back to use scenarios, hazardous behaviors, and separation recommendations so the compliance story is complete.
Many teams are more familiar with the general medical electrical EMC standard YY 9706.102-2021. However, YY/T 1874-2023 is a typical implant-specific standard, and the two standards do not prioritize the same risks.
| Comparison Dimension | YY/T 1874-2023 | YY 9706.102-2021 |
|---|---|---|
| Object of application | Implantable pacemakers, ICDs, and CRT devices | General medical electrical equipment and systems |
| Core concern | Effect of external electromagnetic fields on implanted device function | General emission and immunity requirements of medical equipment |
| Device location | Implanted inside the body | Used outside the body |
| Main risk | Inhibition, inappropriate therapy, permanent parameter change | Interference to others and loss of essential performance |
| Base standard | ISO 14117:2019 | IEC 60601-1-2 |
General EMC standards do not sufficiently cover long-lead coupling, microvolt-level sensing, life-support function behavior, or continuous in-body exposure characteristics. If a team only uses general EMC thinking, it may underestimate risks such as EMI being sensed as cardiac signals, overload during external defibrillation, and magnetic-field mode switching.
For systems that include external companion equipment, the implant itself should follow YY/T 1874-2023, while programmers, monitors, and other external devices should still follow YY 9706.102-2021. In practice, the structure is implant-specific standard plus general standard for peripheral equipment, not one instead of the other.
| Testing Aspect | YY/T 1874-2023 | YY 9706.102-2021 |
|---|---|---|
| Conducted emission | Usually not the main focus | Emission tests on power ports and signal ports |
| Radiated emission | Weakly emphasized or not a primary focus | General emission requirements from 30 MHz to 6 GHz |
| Radiated immunity | Evaluated against implant mode and function-specific criteria | Evaluated against general field strength levels and essential performance |
| Low-frequency magnetic fields | Static field, AC field, and transient exposure are all key items | Usually limited to power-frequency magnetic field immunity |
| Special clinical environments | High-frequency surgery and external defibrillation are dedicated clauses | Not handled as implant-specific risk scenarios |
If you want to apply this standard quickly to project kickoff, test planning, and registration discussion, the terms, takeaways, and references below can serve as practical training material for internal teams.
| Term | English | Meaning |
|---|---|---|
| 心脏起搏器 | Pacemaker | An implantable device used to treat bradycardia |
| 植入式心律转复除颤器 | ICD | An implantable device capable of defibrillation and anti-tachycardia therapy |
| 心脏再同步治疗器械 | CRT | A device intended to improve cardiac function by restoring ventricular synchrony |
| 转换模式 | Fallback mode | A degraded safe operating mode entered by the device under EMI |
| 瞬态暴露 | Transient exposure | An intermittent or short-duration form of electromagnetic exposure |